Oxcarbazepine Tablet, Film Coated
Product Images NDC 68788-7866

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68788-7866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

FDA Label Image

Figure 2 (Oxcarbazepine 03)

Figure 2 (Oxcarbazepine 03)
This text provides information on the seizure rate and the log-rank test with a p-value of 0.046. It also includes a chart with 14 data points displaying the days from the 1st dose to the test seizure for two treatment groups, Oxcarbazepine and Placebo.*
FDA Label Image

Figure 3 (Oxcarbazepine 04)

Figure 3 (Oxcarbazepine 04)
This is a survival analysis output with data on Exitrate and a log-rank test indicating a p-value of 0.0001. The graph shows the time to exit in days for a treatment group labeled as HIGH with different observed values at different time points.*
FDA Label Image

Figure 4 (Oxcarbazepine 05)

Figure 4 (Oxcarbazepine 05)
This is a statistical analysis report. The p-value for a Tog-rank test is shown as 0.0001, indicating a significant difference between two treatment groups, HIGH and LOW. The graph illustrates the time to exit in days for each group.*
FDA Label Image

Oxcarbazepine Tablets 600mg (Oxcarbazepine 08)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.